Search Results 51-60 of 45006 for Two-phase

1. A 2 Part, Phase 2 Trial Of Galeterone In The Treatment Of Castration Resistant Prostate Cancer - Mayo Clinic

   A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients. Participation eligibility.

2. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors - Mayo Clinic

   ... Phase 2 dose for evaluation in these patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

3. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

   A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy ...

4. Phase 2 Study Of TAK-341 For Multiple System Atrophy - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

5. Surgery - Clinical trials

   The purpose of this study is to investigate outcomes for all patients with upper or lower extremity lymphedema with lymph node transfer in a two stage ...

6. Phase 2 Study Of VGT-309 In Lung Cancer - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

7. Phase Ib/II Of TG4001 And Avelumab In HPV16 Positive R/M Cancers - Mayo Clinic

   The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) of TG4001 in combination with avelumab vs avelumab alone in patients with ...

8. Futibatinib And Pembrolizumab For The Treatment Of Advanced Or Metastatic FGF19 Positive BCLC Stage A, B, Or C Liver Cancer - Mayo Clinic

   This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...

9. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

10. Oncology (Medical) - Clinical trials

    This phase II trial compares the impact of ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.